Datamonitor estimates that there were 62.9 million diagnosed active asthma cases in the seven major markets in 2011, and these are forecast to rise to 64.8 million total cases by 2021. Stable prevalence rates and modest population increases are responsible for the small change in the number of cases during this period.
Features and benefits
- Gain insight into market potential, including robust 10-year epidemiology forecasts of active diagnosed prevalent asthma cases.
- Gain insight into relevant clinical severity of active diagnosed asthma cases in the seven major markets.
- Understand the key epidemiologic risk factors associated with asthma.
Highlights
Datamonitor expects to see a small increase in the number of diagnosed active prevalent asthma cases from 2011 to 2021 in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK). The number of asthma cases is expected to increase from approximately 62.9 million cases in 2011 to 64.8 million cases in 2021.
The largest increase in the number of current asthma cases is expected in the US, where between 2011 and 2021 the number of total prevalent cases of asthma will increase by 0.7% annually. Of the seven major markets, only Japan, Italy, and Germany will experience marginal declines in diagnosed prevalent cases of asthma.
Your key questions answered
- What is the number of diagnosed active asthma patients in the seven major markets?
- How will the patient population change over the next decade in these markets?
- What is the severity distribution of diagnosed asthma cases?
Price : Single User License: US$ 7600
Table of Contents
OVERVIEW
Catalyst
Summary
EXECUTIVE SUMMARY
Epidemiology of asthma
Asthma in the seven major markets
Datamonitor’s forecast of asthma
DISEASE DEFINITION AND DIAGNOSTIC CRITERIA
Asthma background
Bronchial challenge test and spirometry can be used for asthma diagnosis
Survey is the usual method for collecting data on asthma prevalence
GLOBAL VARIATION AND HISTORICAL TRENDS
Asthma is significantly underdiagnosed and undertreated worldwide
Asthma prevalence varies widely throughout the world
Asthma causes considerable morbidity, diminished quality of life, and mortality worldwide
Morbidity
Mortality
DRIVERS OF ASTHMA EPIDEMIOLOGY
Risk factors
Genetic factors are associated with risk of development and severity of asthma
Environmental risk factors can lead to a significantly increased risk of asthma symptoms
Breastfeeding may provide a protective effect for asthma
Socioeconomic status influences physical health, including asthma
Occupational exposures are the leading risk factor for asthma development in adulthood
Co-morbid conditions
Asthma and COPD can be confused in diagnosis
Allergic rhinitis and asthma are highly co-morbid
Gastroesophageal reflux disease is the second most common co-morbid condition with asthma
EPIDEMIOLOGIC FORECASTING OF ASTHMA
Overview
Subpopulations
Age and gender
Severity
US
Sources used
Methods
Sources not used
Japan
Sources used
Methods
Sources not used
France
Sources used
Methods
Sources not used
Germany
Sources used
Methods
Sources not used
Italy
Sources used
Methods
Sources not used
Spain
Sources used
Methods
Sources not used
UK
Sources used
Methods
Sources not used
EPIDEMIOLOGIC RESULTS
Current prevalent cases of asthma and future trends
Severity
Age and gender
Age-standardized prevalence rates
DISCUSSION
Strengths and limits of Datamonitor’s epidemiologic projections
Conclusions
BIBLIOGRAPHY
Journal papers
Websites
List of Tables
Table: ICD-10 codes associated with asthma
Table: Data sources used to estimate asthma prevalent cases
Table: Global Initiative for Asthma guidelines on severity
Table: Total prevalent cases of current asthma in all ages in the seven major markets (000s), 2011–21
Table: Total prevalent cases of current asthma in each of the seven major markets, by severity (000s), 2011
Table: Age-specific prevalent cases of diagnosed active asthma in the seven major markets, 2011
Table: Age-standardized prevalence rates (per 100,000) of active diagnosed asthma in the seven major markets, by gender, 2011
List of Figures
Figure: Proportion of age-specific prevalent cases in the seven major markets, 2011
Figure: Age-standardized prevalence rates (per 100,000) of active diagnosed asthma in the seven major markets, by gender, 2011
Contact [email protected] for further details.
